IBDEI1M8 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27411,1,3,0)
 ;;=3^Tubulo-Interstitial Nephritis
 ;;^UTILITY(U,$J,358.3,27411,1,4,0)
 ;;=4^N12.
 ;;^UTILITY(U,$J,358.3,27411,2)
 ;;=^5015575
 ;;^UTILITY(U,$J,358.3,27412,0)
 ;;=L97.509^^106^1354^4
 ;;^UTILITY(U,$J,358.3,27412,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27412,1,3,0)
 ;;=3^Non-Pressure Chr Ulcer Unspec Foot w/ Unspec Severity
 ;;^UTILITY(U,$J,358.3,27412,1,4,0)
 ;;=4^L97.509
 ;;^UTILITY(U,$J,358.3,27412,2)
 ;;=^5009544
 ;;^UTILITY(U,$J,358.3,27413,0)
 ;;=M86.10^^106^1354^5
 ;;^UTILITY(U,$J,358.3,27413,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27413,1,3,0)
 ;;=3^Osteomylitis,Acute,Unspec Site
 ;;^UTILITY(U,$J,358.3,27413,1,4,0)
 ;;=4^M86.10
 ;;^UTILITY(U,$J,358.3,27413,2)
 ;;=^5014521
 ;;^UTILITY(U,$J,358.3,27414,0)
 ;;=E85.9^^106^1355^1
 ;;^UTILITY(U,$J,358.3,27414,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27414,1,3,0)
 ;;=3^Amyloidosis,Unspec
 ;;^UTILITY(U,$J,358.3,27414,1,4,0)
 ;;=4^E85.9
 ;;^UTILITY(U,$J,358.3,27414,2)
 ;;=^334185
 ;;^UTILITY(U,$J,358.3,27415,0)
 ;;=N00.9^^106^1355^3
 ;;^UTILITY(U,$J,358.3,27415,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27415,1,3,0)
 ;;=3^Nephritic Syndrome w/ Morphologic Changes,Acute
 ;;^UTILITY(U,$J,358.3,27415,1,4,0)
 ;;=4^N00.9
 ;;^UTILITY(U,$J,358.3,27415,2)
 ;;=^5015500
 ;;^UTILITY(U,$J,358.3,27416,0)
 ;;=N08.^^106^1355^2
 ;;^UTILITY(U,$J,358.3,27416,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27416,1,3,0)
 ;;=3^Glomerular Disorders in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,27416,1,4,0)
 ;;=4^N08.
 ;;^UTILITY(U,$J,358.3,27416,2)
 ;;=^5015569
 ;;^UTILITY(U,$J,358.3,27417,0)
 ;;=N03.9^^106^1355^4
 ;;^UTILITY(U,$J,358.3,27417,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27417,1,3,0)
 ;;=3^Nephritic Syndrome w/ Morphologic Changes,Chronic
 ;;^UTILITY(U,$J,358.3,27417,1,4,0)
 ;;=4^N03.9
 ;;^UTILITY(U,$J,358.3,27417,2)
 ;;=^5015530
 ;;^UTILITY(U,$J,358.3,27418,0)
 ;;=N05.8^^106^1356^1
 ;;^UTILITY(U,$J,358.3,27418,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27418,1,3,0)
 ;;=3^Nephritic Syndrome w/ Morphologic Changes,Unspec
 ;;^UTILITY(U,$J,358.3,27418,1,4,0)
 ;;=4^N05.8
 ;;^UTILITY(U,$J,358.3,27418,2)
 ;;=^5134085
 ;;^UTILITY(U,$J,358.3,27419,0)
 ;;=M30.0^^106^1357^2
 ;;^UTILITY(U,$J,358.3,27419,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27419,1,3,0)
 ;;=3^Polyarteritis Nodosa
 ;;^UTILITY(U,$J,358.3,27419,1,4,0)
 ;;=4^M30.0
 ;;^UTILITY(U,$J,358.3,27419,2)
 ;;=^5011738
 ;;^UTILITY(U,$J,358.3,27420,0)
 ;;=N04.9^^106^1357^1
 ;;^UTILITY(U,$J,358.3,27420,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27420,1,3,0)
 ;;=3^Nephrotic Syndrome w/ Morphologic Changes
 ;;^UTILITY(U,$J,358.3,27420,1,4,0)
 ;;=4^N04.9
 ;;^UTILITY(U,$J,358.3,27420,2)
 ;;=^5015540
 ;;^UTILITY(U,$J,358.3,27421,0)
 ;;=N13.30^^106^1358^2
 ;;^UTILITY(U,$J,358.3,27421,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27421,1,3,0)
 ;;=3^Hydronephrosis,Unspec
 ;;^UTILITY(U,$J,358.3,27421,1,4,0)
 ;;=4^N13.30
 ;;^UTILITY(U,$J,358.3,27421,2)
 ;;=^5015578
 ;;^UTILITY(U,$J,358.3,27422,0)
 ;;=N13.9^^106^1358^12
 ;;^UTILITY(U,$J,358.3,27422,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27422,1,3,0)
 ;;=3^Uropathy,Obstructive & Reflux,Unspec
 ;;^UTILITY(U,$J,358.3,27422,1,4,0)
 ;;=4^N13.9
 ;;^UTILITY(U,$J,358.3,27422,2)
 ;;=^5015589
 ;;^UTILITY(U,$J,358.3,27423,0)
 ;;=N40.1^^106^1358^1
 ;;^UTILITY(U,$J,358.3,27423,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27423,1,3,0)
 ;;=3^Enlarged Prostate w/ LUTS
 ;;^UTILITY(U,$J,358.3,27423,1,4,0)
 ;;=4^N40.1
 ;;^UTILITY(U,$J,358.3,27423,2)
 ;;=^5015690
 ;;^UTILITY(U,$J,358.3,27424,0)
 ;;=R39.14^^106^1358^3
